Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine

Victor M. Aquino, Daniel C. Douek, Brian Berryman, Matthew Johnson, Vinay K. Jain, Robert H. Collins

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The role of the thymus in immune reconstitution in adults receiving chemotherapy is controversial. Detection of T-cell-receptor gene rearrangement excisional circles (TREC) in peripheral blood T cells has been shown to estimate thymic output. Therefore, we measured TREC levels to assess the contribution of the thymus to immune recovery following treatment with fludarabine. Patients who had received fludarabine alone or a fludarabine containing regimen were identified. Cryopreserved peripheral-blood mononuclear cells were obtained and analyzed by four-color flow cytometry utilizing fluorochrome-conjugated antibodies against CD4, CD8, CD45RO and CD27. Proportions of naïve T cells in each CD4+ and CD8+ subset were measured by gating on CD45RO-negative, CD27+ cells. Quantification of TREC in sorted naïve CD4+ and CD8+ T cells was performed by real-time PCR. Thirteen patients received a mean of 3.8 ± 0.4 courses of fludarabine and samples were obtained at a average of 18.8 (range 3.6-40.3) months after completing chemotherapy. Ten (77%) had detectable TREC levels. There was a positive correlation (Spearman's rank correlation) between the degree of TREC expression and the percentage of naïve T cells (r = 0.6, p = 0.03), naïve CD4+ (r = 0.6, p = 0.03) and naïve CD8+ (r = 0.66, p = 0.01) cells. We conclude that increased thymic output as demonstrated by an increase in TREC levels correlated with, and was predictive of, increased numbers of naïve T cell following fludarabine administration. The thymus appears to play a role in immune recovery in adults after receiving chemotherapy.

Original languageEnglish (US)
Pages (from-to)343-348
Number of pages6
JournalLeukemia and Lymphoma
Volume44
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
T-Lymphocytes
Thymus Gland
Drug Therapy
Blood Cells
Fluorescent Dyes
fludarabine
Real-Time Polymerase Chain Reaction
Flow Cytometry
Color
Antibodies

Keywords

  • Fludarabine therapy
  • Four-color flow cytometry
  • T cell receptor gen rearragment excisional circles
  • Thymic output

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine. / Aquino, Victor M.; Douek, Daniel C.; Berryman, Brian; Johnson, Matthew; Jain, Vinay K.; Collins, Robert H.

In: Leukemia and Lymphoma, Vol. 44, No. 2, 01.02.2003, p. 343-348.

Research output: Contribution to journalArticle

@article{508eafb21aa649adbc2564475a3a7b66,
title = "Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine",
abstract = "The role of the thymus in immune reconstitution in adults receiving chemotherapy is controversial. Detection of T-cell-receptor gene rearrangement excisional circles (TREC) in peripheral blood T cells has been shown to estimate thymic output. Therefore, we measured TREC levels to assess the contribution of the thymus to immune recovery following treatment with fludarabine. Patients who had received fludarabine alone or a fludarabine containing regimen were identified. Cryopreserved peripheral-blood mononuclear cells were obtained and analyzed by four-color flow cytometry utilizing fluorochrome-conjugated antibodies against CD4, CD8, CD45RO and CD27. Proportions of na{\"i}ve T cells in each CD4+ and CD8+ subset were measured by gating on CD45RO-negative, CD27+ cells. Quantification of TREC in sorted na{\"i}ve CD4+ and CD8+ T cells was performed by real-time PCR. Thirteen patients received a mean of 3.8 ± 0.4 courses of fludarabine and samples were obtained at a average of 18.8 (range 3.6-40.3) months after completing chemotherapy. Ten (77{\%}) had detectable TREC levels. There was a positive correlation (Spearman's rank correlation) between the degree of TREC expression and the percentage of na{\"i}ve T cells (r = 0.6, p = 0.03), na{\"i}ve CD4+ (r = 0.6, p = 0.03) and na{\"i}ve CD8+ (r = 0.66, p = 0.01) cells. We conclude that increased thymic output as demonstrated by an increase in TREC levels correlated with, and was predictive of, increased numbers of na{\"i}ve T cell following fludarabine administration. The thymus appears to play a role in immune recovery in adults after receiving chemotherapy.",
keywords = "Fludarabine therapy, Four-color flow cytometry, T cell receptor gen rearragment excisional circles, Thymic output",
author = "Aquino, {Victor M.} and Douek, {Daniel C.} and Brian Berryman and Matthew Johnson and Jain, {Vinay K.} and Collins, {Robert H.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1080/1042819021000029696",
language = "English (US)",
volume = "44",
pages = "343--348",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine

AU - Aquino, Victor M.

AU - Douek, Daniel C.

AU - Berryman, Brian

AU - Johnson, Matthew

AU - Jain, Vinay K.

AU - Collins, Robert H.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - The role of the thymus in immune reconstitution in adults receiving chemotherapy is controversial. Detection of T-cell-receptor gene rearrangement excisional circles (TREC) in peripheral blood T cells has been shown to estimate thymic output. Therefore, we measured TREC levels to assess the contribution of the thymus to immune recovery following treatment with fludarabine. Patients who had received fludarabine alone or a fludarabine containing regimen were identified. Cryopreserved peripheral-blood mononuclear cells were obtained and analyzed by four-color flow cytometry utilizing fluorochrome-conjugated antibodies against CD4, CD8, CD45RO and CD27. Proportions of naïve T cells in each CD4+ and CD8+ subset were measured by gating on CD45RO-negative, CD27+ cells. Quantification of TREC in sorted naïve CD4+ and CD8+ T cells was performed by real-time PCR. Thirteen patients received a mean of 3.8 ± 0.4 courses of fludarabine and samples were obtained at a average of 18.8 (range 3.6-40.3) months after completing chemotherapy. Ten (77%) had detectable TREC levels. There was a positive correlation (Spearman's rank correlation) between the degree of TREC expression and the percentage of naïve T cells (r = 0.6, p = 0.03), naïve CD4+ (r = 0.6, p = 0.03) and naïve CD8+ (r = 0.66, p = 0.01) cells. We conclude that increased thymic output as demonstrated by an increase in TREC levels correlated with, and was predictive of, increased numbers of naïve T cell following fludarabine administration. The thymus appears to play a role in immune recovery in adults after receiving chemotherapy.

AB - The role of the thymus in immune reconstitution in adults receiving chemotherapy is controversial. Detection of T-cell-receptor gene rearrangement excisional circles (TREC) in peripheral blood T cells has been shown to estimate thymic output. Therefore, we measured TREC levels to assess the contribution of the thymus to immune recovery following treatment with fludarabine. Patients who had received fludarabine alone or a fludarabine containing regimen were identified. Cryopreserved peripheral-blood mononuclear cells were obtained and analyzed by four-color flow cytometry utilizing fluorochrome-conjugated antibodies against CD4, CD8, CD45RO and CD27. Proportions of naïve T cells in each CD4+ and CD8+ subset were measured by gating on CD45RO-negative, CD27+ cells. Quantification of TREC in sorted naïve CD4+ and CD8+ T cells was performed by real-time PCR. Thirteen patients received a mean of 3.8 ± 0.4 courses of fludarabine and samples were obtained at a average of 18.8 (range 3.6-40.3) months after completing chemotherapy. Ten (77%) had detectable TREC levels. There was a positive correlation (Spearman's rank correlation) between the degree of TREC expression and the percentage of naïve T cells (r = 0.6, p = 0.03), naïve CD4+ (r = 0.6, p = 0.03) and naïve CD8+ (r = 0.66, p = 0.01) cells. We conclude that increased thymic output as demonstrated by an increase in TREC levels correlated with, and was predictive of, increased numbers of naïve T cell following fludarabine administration. The thymus appears to play a role in immune recovery in adults after receiving chemotherapy.

KW - Fludarabine therapy

KW - Four-color flow cytometry

KW - T cell receptor gen rearragment excisional circles

KW - Thymic output

UR - http://www.scopus.com/inward/record.url?scp=0037300571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037300571&partnerID=8YFLogxK

U2 - 10.1080/1042819021000029696

DO - 10.1080/1042819021000029696

M3 - Article

C2 - 12688355

AN - SCOPUS:0037300571

VL - 44

SP - 343

EP - 348

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -